Meadow Creek Investment Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$8.39M Buy
43,360
+2,320
+6% +$445K 0.17% 109
2019
Q2
$7.56M Buy
41,040
+14,704
+56% +$2.63M 0.15% 131
2019
Q1
$5M Buy
26,336
+6,352
+32% +$1.21M 0.1% 181
2018
Q4
$3.89M Buy
19,984
+4,624
+30% +$902K 0.09% 213
2018
Q3
$3.18M Sell
15,360
-2,784
-15% -$549K 0.06% 267
2018
Q2
$3.35M Sell
18,144
-10,960
-38% -$1.94M 0.07% 246
2018
Q1
$4.96M Sell
29,104
-4,208
-13% -$772K 0.11% 185
2017
Q4
$5.79M Buy
33,312
+4,432
+15% +$784K 0.13% 159
2017
Q3
$5.38M Sell
28,880
-1,600
-5% -$283K 0.13% 159
2017
Q2
$5.25M Buy
30,480
+5,280
+21% +$859K 0.13% 151
2017
Q1
$4.13M Buy
25,200
+4,608
+22% +$766K 0.1% 185
2016
Q4
$3.01M Buy
+20,592
New +$3.1M 0.08% 199

Other funds holding AMGN

Meadow Creek Investment Management's AMGN Position: Q3 2019 in Review

Meadow Creek Investment Management increased its Amgen (AMGN) stake by 5.7% in Q3 2019, buying an estimated $445K and bringing the position to 43,360 shares worth $8.39M. The position accounts for 0.17% of the portfolio, ranked #109.

Meadow Creek Investment Management first reported a position in AMGN in Q4 2016 and has held it in 12 quarters since. 1,883 funds tracked by Wall St. Rank hold AMGN as of Q3 2019.

  • Meadow Creek Investment Management held 43,360 shares of Amgen worth $8.39M as of Q3 2019.
  • Meadow Creek Investment Management bought 2,320 Amgen shares in Q3 2019, an estimated $445K.
  • Amgen made up 0.17% of Meadow Creek Investment Management's portfolio in Q3 2019, its #109 holding.
  • Meadow Creek Investment Management first reported a position in Amgen in Q4 2016 and has held it in 12 quarters since.
  • 1,883 funds tracked by Wall St. Rank held Amgen as of Q3 2019.

Based on Meadow Creek Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.